HPV News
Most Popular HPV Story
Older women unlikely to benefit from HPV vax
A new study concludes that women over the age of 40 are unlikely to benefit from an HPV vaccine. Researchers tracked the experiences of 9,000 Costa Rican women ages 19 to 97 years, screening them for... Read more...
Latest Headlines
- February 25, 2010
- January 20, 2010
- November 5, 2009
- September 17, 2009
- September 10, 2009
- September 2, 2009
- August 27, 2009
- March 26, 2009
- March 25, 2009
- February 11, 2009
- November 20, 2008
- November 10, 2008
- September 4, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
